Skip to content
DataLookout
Menu

ScarABEONCT06906237

Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 2 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 11 words
    • Primary completion pushed from Oct 1, 2026 to Dec 1, 2026
    • Study completion pushed from Dec 1, 2026 to Jun 1, 2027
  2. Notable Primary completion date: Oct 1, 2025 to Oct 1, 2026
    • Study completion date: Dec 1, 2025 to Dec 1, 2026
    v4
  3. Minor Primary completion date: Sep 1, 2025 to Oct 1, 2025
    • Start date changed from estimate of May 1, 2025 to Apr 18, 2024
    v3
  4. Minor Trial status: Enrolling by Invitation to Recruiting
    • Site details revised
    v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Margin infiltration rate
Timeframe: Perioperative

Secondary (6)

Re-excisions rate
Total resection volume and final breast volume ratio
Post-operative complication rates
Post-operative breast symmetry
Disease-free survival
Show 1 moreShow less
Overall Survival

Sites

1 site in 1 country

  • Veneto Institute of OncologyPadova, Italy